← All trials
NCT05982704
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Aug 18, 2022
- Primary completion
- Sep 19, 2022
- Completion date
- Nov 1, 2023
- First posted
- Aug 8, 2023
- Last posted
- Aug 8, 2023
- Enrollment
- 82
- Arms / groups
- 3 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Government of RussiaLead sponsor
- Government of RussiaCollaborator
- Government of RussiaReponsible party - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.